These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25554966)

  • 21. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.
    Shonka DC; Shoushtari AN; Thomas CY; Moskaluk C; Read PW; Reibel JF; Levine PA; Jameson MJ
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1126-32. PubMed ID: 19917926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Expression of CD44, a Cancer Stem Cell Marker, on the Treatment Outcomes of Intensity Modulated Radiation Therapy in Patients With Oropharyngeal Squamous Cell Carcinoma.
    Motegi A; Fujii S; Zenda S; Arahira S; Tahara M; Hayashi R; Akimoto T
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):461-8. PubMed ID: 26867875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
    Lin CM; Lin LW; Chen YW; Ye YL
    Cancer Immunol Immunother; 2020 Apr; 69(4):549-558. PubMed ID: 31970439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.
    Kumar B; Yadav A; Brown NV; Zhao S; Cipolla MJ; Wakely PE; Schmitt AC; Baiocchi RA; Teknos TN; Old M; Kumar P
    Oncotarget; 2017 Feb; 8(9):14847-14859. PubMed ID: 28107179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oropharyngeal Squamous Cell Carcinoma in 390 Patients: Analysis of Clinical and Histological Criteria Which Significantly Impact Outcome.
    Thompson LDR; Burchette R; Iganej S; Bhattasali O
    Head Neck Pathol; 2020 Sep; 14(3):666-688. PubMed ID: 31741151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Significance of p16 Cellular Localization in Oropharyngeal Squamous Cell Carcinoma.
    Lai S; Wenaas AE; Sandulache VC; Hartman C; Chiao E; Kramer J; Zevallos JP
    Ann Clin Lab Sci; 2016; 46(2):132-9. PubMed ID: 27098618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
    Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y
    Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.
    Meyer JE; Panico VJ; Marconato HM; Sherr DL; Christos P; Pirog EC
    J Gastrointest Cancer; 2013 Dec; 44(4):450-5. PubMed ID: 24014082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers.
    Lewis JS; Scantlebury JB; Luo J; Thorstad WL
    Am J Surg Pathol; 2012 Jul; 36(7):1036-46. PubMed ID: 22743286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival and swallowing outcomes in advanced stage oropharyngeal squamous cell carcinomas.
    Clark JM; Holmes EM; O'Connell DA; Harris J; Seikaly H; Biron VL
    Papillomavirus Res; 2019 Jun; 7():1-10. PubMed ID: 30267774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer.
    Lin RJ; Lubpairee T; Liu KY; Anderson DW; Durham S; Poh CF
    J Otolaryngol Head Neck Surg; 2013 Mar; 42(1):23. PubMed ID: 23672832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
    Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma.
    de C Ferreira C; Dufloth R; de Carvalho AC; Reis RM; Santana I; Carvalho RS; Gama RR
    PLoS One; 2021; 16(6):e0253418. PubMed ID: 34138935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.